NVDA · Nvidia Corp

Pro-rated annual grant in connection with service on the Board of Directors. The shares represent restricted stock units that were received as an award, for no consideration. The restricted stock unit shall vest as to 543 shares on November 18, 2026 and 605 shares on May 19, 2027. If the Reporting Person's service as a director terminates at any time due to death, the grant shall immediately become fully vested.

Initial grant in connection with appointment to the Board of Directors. The shares represent restricted stock units that were received as an award, for no consideration. The restricted stock unit shall vest as to 1/6th of the shares on March 17, 2027 and 1/6th of the shares approximately every six months thereafter, such that the shares are fully vested on approximately the three (3) year anniversary of the date of grant. If the Reporting Person's service as a director terminates at any time due to death, the grant shall immediately become fully vested.

The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 19, 2026.

Gift without consideration.

Shares held by a trust of which the reporting person is a trustee. The reporting person disclaims beneficial ownership in these shares except as to the reporting person's pecuniary interest in the trust.

The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 19, 2026.

Gift without consideration.

Shares held by a trust of which the reporting person is a trustee. The reporting person disclaims beneficial ownership in these shares except as to the reporting person's pecuniary interest in the trust.

Annual grant in connection with service on the Board of Directors. The shares represent restricted stock units that were received as an award, for no consideration. The restricted stock units shall vest as to 50% of the shares on November 18, 2026 and 50% of the shares on May 19, 2027. If the Reporting Person's service as a director terminates at any time due to death, the grant shall immediately become fully vested.

Annual grant in connection with service on the Board of Directors. The shares represent restricted stock units that were received as an award, for no consideration. The restricted stock units shall vest as to 50% of the shares on November 18, 2026 and 50% of the shares on May 19, 2027. If the Reporting Person's service as a director terminates at any time due to death, the grant shall immediately become fully vested.

Annual grant in connection with service on the Board of Directors. The shares represent restricted stock units that were received as an award, for no consideration. The restricted stock units shall vest as to 50% of the shares on November 18, 2026 and 50% of the shares on May 19, 2027. If the Reporting Person's service as a director terminates at any time due to death, the grant shall immediately become fully vested.

Reflects 1,799 shares transferred without consideration from the Reporting Person to a family trust (the "Trust"), of which the Reporting Person and her spouse are cotrustees.

Annual grant in connection with service on the Board of Directors. The shares represent restricted stock units that were received as an award, for no consideration. The restricted stock units shall vest as to 50% of the shares on November 18, 2026 and 50% of the shares on May 19, 2027. If the Reporting Person's service as a director terminates at any time due to death, the grant shall immediately become fully vested.

Annual grant in connection with service on the Board of Directors. The shares represent restricted stock units that were received as an award, for no consideration. The restricted stock units shall vest as to 50% of the shares on November 18, 2026 and 50% of the shares on May 19, 2027. If the Reporting Person's service as a director terminates at any time due to death, the grant shall immediately become fully vested.

Annual grant in connection with service on the Board of Directors. The shares represent restricted stock units that were received as an award, for no consideration. The restricted stock units shall vest as to 50% of the shares on November 18, 2026 and 50% of the shares on May 19, 2027. If the Reporting Person's service as a director terminates at any time due to death, the grant shall immediately become fully vested.

Annual grant in connection with service on the Board of Directors. The shares represent restricted stock units that were received as an award, for no consideration. The restricted stock units shall vest as to 50% of the shares on November 18, 2026 and 50% of the shares on May 19, 2027. If the Reporting Person's service as a director terminates at any time due to death, the grant shall immediately become fully vested.

Annual grant in connection with service on the Board of Directors. The shares represent restricted stock units that were received as an award, for no consideration. The restricted stock units shall vest as to 50% of the shares on November 18, 2026 and 50% of the shares on May 19, 2027. If the Reporting Person's service as a director terminates at any time due to death, the grant shall immediately become fully vested.

Annual grant in connection with service on the Board of Directors. The shares represent restricted stock units that were received as an award, for no consideration. The restricted stock units shall vest as to 50% of the shares on November 18, 2026 and 50% of the shares on May 19, 2027. If the Reporting Person's service as a director terminates at any time due to death, the grant shall immediately become fully vested.

Represents weighted average sales price. The shares were sold at prices ranging from $209.0600 to $210.0594. The Reporting Person will provide upon request, to the Securities and Exchange Commission (the "SEC"), the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

Held by the Third Millennium Trust, of which the Reporting Person and his wife are co-trustees.

Represents weighted average sales price. The shares were sold at prices ranging from $210.0598 to $211.0100. The Reporting Person will provide upon request, to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

Held by the Third Millennium Trust, of which the Reporting Person and his wife are co-trustees.

Represents shares withheld by the Issuer to satisfy taxes due by the Reporting Person in connection with the vesting of restricted stock units previously reported on a Form 4.

Includes 36,301 shares issued upon the vesting of restricted stock units previously reported on a Form 4.

Represents shares withheld by the Issuer to satisfy taxes due by the Reporting Person in connection with the vesting of restricted stock units previously reported on a Form 4.

Includes 31,193 shares issued upon the vesting of restricted stock units previously reported on a Form 4.

Represents shares withheld by the Issuer to satisfy taxes due by the Reporting Person in connection with the vesting of restricted stock units previously reported on a Form 4.

Includes 30,463 shares issued upon the vesting of restricted stock units previously reported on a Form 4.

Reflects 30,463 shares transferred without consideration from the Reporting Person to The Horne Teter Family Living Trust, dated 02/01/2019 (the "Trust"), of which the Reporting Person is trustee.

Represents shares withheld by the Issuer to satisfy taxes due by the Reporting Person in connection with the vesting of restricted stock units previously reported on a Form 4.

Includes 46,495 shares issued upon the vesting of restricted stock units previously reported on a Form 4.

Represents shares withheld by the Issuer to satisfy taxes due by the Reporting Person in connection with the vesting of restricted stock units previously reported on a Form 4.

Includes 37,548 shares issued upon the vesting of restricted stock units previously reported on a Form 4.

(1) Gifts without consideration by the Jen-Hsun & Lori Huang Living Trust, u/a/d May 1, 1995 (the "Trust"), of 266,670 shares to The Jen-Hsun & Lori Huang Foundation, a 501(c)(3) charitable organization, and 133,330 shares to a donor-advised fund.

Represents 30,000,000 shares contributed to each of TARG S3 and TARG M3.

The shares are held by Jen-Hsun Huang and Lori Huang, as co-trustees of the Trust.

The restricted stock units ("RSUs") shall vest as to 10% of the shares on September 16, 2026 and every three months thereafter for three quarters, as to 7.5% of the shares every three months thereafter for four quarters, as to 5% of the shares every three months thereafter for four quarters, and as to 2.5% of the shares every three months thereafter for four quarters, such that the shares are fully vested on approximately the four (4) year anniversary of the date of grant.

The shares represent RSUs that were received as an award, for no consideration.

The RSUs shall vest as to 6.25% of the shares on September 16, 2026 and 6.25% of the shares every three months thereafter, such that the shares are fully vested on approximately the four (4) year anniversary of the date of grant.

The shares represent RSUs that were received as an award, for no consideration.

Gift without consideration.

Held by the Third Millennium Trust, of which the Reporting Person and his wife are co-trustees.

Represents weighted average sales price. The shares were sold at prices ranging from $217.500 to $217.820. The Reporting Person will provide upon request, to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

Held by the Third Millennium Trust, of which the Reporting Person and his wife are co-trustees.

Represents weighted average sales price. The shares were sold at prices ranging from $220.000 to $220.930. The Reporting Person will provide upon request, to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

Held by the Third Millennium Trust, of which the Reporting Person and his wife are co-trustees.

Represents weighted average sales price. The shares were sold at prices ranging from $215.680 to $215.790. The Reporting Person will provide upon request, to the Securities and Exchange Commission, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

Reflects 11,775 shares transferred without consideration from the Neal/Rhyu Revocable Trust dated 5/2/2017 (the "Trust") to the 2013 Stephen C. Neal Revocable Trust (the "Neal Revocable Trust").

Shares held by the Trust, of which the Reporting Person is trustee.

Represents weighted average sales price. The shares were sold at prices ranging from $222.000 to $222.890. The Reporting Person will provide upon request, to the Securities and Exchange Commission (the "SEC"), the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

Held by the Third Millennium Trust, of which the Reporting Person and his wife are co-trustees.

The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 10, 2025.

The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 4, 2025.

Represents weighted average sales price. The shares were sold at prices ranging from $177.220 to $177.915. The Reporting Person will provide upon request, to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 18, 2025.

Represents weighted average sales price. The shares were sold at prices ranging from $172.860 to $173.070. The Reporting Person will provide upon request, to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

Represents weighted average sales price. The shares were sold at prices ranging from $174.310 to $175.005. The Reporting Person will provide upon request, to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

Held by the Third Millennium Trust, of which the Reporting Person and his wife are co-trustees.

The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 4, 2025.

Represents weighted average sales price. The shares were sold at prices ranging from $176.215 to $177.210. The Reporting Person will provide upon request, to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 4, 2025.

Represents weighted average sales price. The shares were sold at prices ranging from $173.215 to $174.205. The Reporting Person will provide upon request, to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 4, 2025.

Represents weighted average sales price. The shares were sold at prices ranging from $177.220 to $177.915. The Reporting Person will provide upon request, to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 18, 2025.

Represents weighted average sales price. The shares were sold at prices ranging from $175.360 to $176.190. The Reporting Person will provide upon request, to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 4, 2025.

Represents weighted average sales price. The shares were sold at prices ranging from $174.215 to $175.205. The Reporting Person will provide upon request, to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 4, 2025.

Represents weighted average sales price. The shares were sold at prices ranging from $176.215 to $177.210. The Reporting Person will provide upon request, to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 4, 2025.

Represents weighted average sales price. The shares were sold at prices ranging from $173.215 to $174.205. The Reporting Person will provide upon request, to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

Represents weighted average sales price. The shares were sold at prices ranging from $172.600 to $172.630. The Reporting Person will provide upon request, to the Securities and Exchange Commission (the "SEC"), the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

Held by the Third Millennium Trust, of which the Reporting Person and his wife are co-trustees.

The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 4, 2025.

Represents weighted average sales price. The shares were sold at prices ranging from $171.850 to $172.180. The Reporting Person will provide upon request, to the Securities and Exchange Commission (the "SEC"), the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 18, 2025.

Represents weighted average sales price. The shares were sold at prices ranging from $173.390 to $174.120. The Reporting Person will provide upon request, to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 4, 2025.

Represents weighted average sales price. The shares were sold at prices ranging from $171.850 to $172.180. The Reporting Person will provide upon request, to the Securities and Exchange Commission (the "SEC"), the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 4, 2025.

Represents weighted average sales price. The shares were sold at prices ranging from $174.215 to $175.205. The Reporting Person will provide upon request, to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 4, 2025.

Represents weighted average sales price. The shares were sold at prices ranging from $175.215 to $176.210. The Reporting Person will provide upon request, to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 4, 2025.

Represents weighted average sales price. The shares were sold at prices ranging from $175.215 to $176.210. The Reporting Person will provide upon request, to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 18, 2025.

Represents weighted average sales price. The shares were sold at prices ranging from $172.070 to $172.850. The Reporting Person will provide upon request, to the Securities and Exchange Commission (the "SEC"), the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 4, 2025.

Represents weighted average sales price. The shares were sold at prices ranging from $177.220 to $177.915. The Reporting Person will provide upon request, to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.

The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 4, 2025.

Represents weighted average sales price. The shares were sold at prices ranging from $175.215 to $176.210. The Reporting Person will provide upon request, to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.